Cathie Wood - ARK Invest Portfolio
Period Date | Jun 30, 2025 | |
Filing Date | Jul 30, 2025 | |
Total Stocks | 191 | |
Portfolio Value | $13.64B |
ARK Invest Activity
Date | Symbol | Type | Quantity |
---|---|---|---|
Q3 2019Sep 30, 2019 | BWAY Brainsway Ltd. | Sell - Position Exit | -82,313-100.0% |
Q3 2019Sep 30, 2019 | META Meta Platforms, Inc. | Sell | -157,422-96.8% |
Q3 2019Sep 30, 2019 | PDD PDD Holdings Inc. | Sell | -212,309-31.8% |
Q3 2019Sep 30, 2019 | JMIA Jumia Technologies AG | Sell - Position Exit | -272,881-100.0% |
Q3 2019Sep 30, 2019 | GBTC Grayscale Bitcoin Trust (BTC) | Sell | -280,380-16.4% |
Q3 2019Sep 30, 2019 | TER Teradyne, Inc. | Sell | -376,872-28.3% |
Q3 2019Sep 30, 2019 | VCYT Veracyte, Inc. | Sell | -453,855-14.9% |
Q3 2019Sep 30, 2019 | BIDU Baidu, Inc. | Sell | -497,692-78.8% |
Q3 2019Sep 30, 2019 | NVDA NVIDIA Corporation | Sell | -540,919-50.5% |
Q3 2019Sep 30, 2019 | TCEHY Tencent Holding Ltd. | Sell | -581,888-32.9% |
Q3 2019Sep 30, 2019 | NTNX Nutanix, Inc. | Sell | -1,202,588-85.2% |
Q3 2019Sep 30, 2019 | LC LendingClub Corporation | Sell | -16,575,196-80.2% |
Q2 2019Jun 30, 2019 | LC LendingClub Corporation | Buy - Position Entry | +20,659,636 |
Q2 2019Jun 30, 2019 | MCRB Seres Therapeutics, Inc. | Buy | +1,751,172+33.1% |
Q2 2019Jun 30, 2019 | NTNX Nutanix, Inc. | Buy | +1,224,081+651.0% |
Q2 2019Jun 30, 2019 | ARCT Arcturus Therapeutics Holdings | Buy - Position Entry | +1,004,368 |
Q2 2019Jun 30, 2019 | EB Eventbrite, Inc. | Buy | +915,824+125.1% |
Q2 2019Jun 30, 2019 | CERS Cerus Corporation | Buy | +853,589+11.2% |
Q2 2019Jun 30, 2019 | TSLA Tesla, Inc. | Buy | +409,332+54.3% |
Q2 2019Jun 30, 2019 | SQ Block, Inc. | Buy | +373,765+17.5% |
Q2 2019Jun 30, 2019 | EDIT Editas Medicine, Inc. | Buy | +288,714+6.3% |
Q2 2019Jun 30, 2019 | JMIA Jumia Technologies AG | Buy - Position Entry | +272,881 |
Q2 2019Jun 30, 2019 | NTLA Intellia Therapeutics, Inc. | Buy | +261,967+3.3% |
Q2 2019Jun 30, 2019 | PDD PDD Holdings Inc. | Buy | +257,821+62.9% |
Q2 2019Jun 30, 2019 | TDOC Teladoc Health, Inc. | Buy | +240,886+32.7% |
Q2 2019Jun 30, 2019 | FATE Fate Therapeutics, Inc. | Buy - Position Entry | +222,064 |
Q2 2019Jun 30, 2019 | TWST Twist Bioscience Corporation | Buy - Position Entry | +213,793 |
Q2 2019Jun 30, 2019 | PSNL Personalis, Inc. | Buy - Position Entry | +197,720 |
Q2 2019Jun 30, 2019 | PRLB Proto Labs, Inc. | Buy | +179,626+61.7% |
Q2 2019Jun 30, 2019 | CLLS Cellectis S.A. | Buy | +169,110+18.1% |